Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy

INTRODUCTION: Personalized treatment for patients with membranous nephropathy requires accurate prediction of the disease course at an early stage. In this study, we evaluated the value of baseline anti–phospholipase A2 receptor (PLA2R1) antibody titer as a prognostic biomarker in patients with PLA2...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int Rep
Autors principals: Logt, Anne-Els van de, Justino, Joana, Vink, Coralien H., van den Brand, Jan, Debiec, Hanna, Lambeau, Gérard, Wetzels, Jack F.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207302/
https://ncbi.nlm.nih.gov/pubmed/34169209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2021.04.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars